Chemomab Therapeutics Ltd.
nebokitug
primary sclerosing cholangitis (PSC)
Date
TBD
Phase 3 readout Β· Date TBD estimated
What's at stake
Phase 3 trial results for nebokitug in primary sclerosing cholangitis (PSC) are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
Β· SEC 6-K
verified 15h ago
βa Phase 3 clinical trial.β